S'pore researchers to study stem cell transplants in brain for Parkinson's disease in novel trial
Researchers involved in the project include (from left) Professor Lim Kah Leong, President's Chair in Translational Neuroscience at the Lee Kong Chian School of Medicine; Associate Professor Prakash Kumar, head and senior consultant at the department of neurology at the National Neuroscience Institute (NNI); Professor Louis Tan, NNI's director of research; and Professor Tan Eng King, NNI's deputy chief executive officer for academic affairs. ST PHOTO: NG SOR LUAN
S'pore researchers to study stem cell transplants in brain for Parkinson's disease in novel trial
SINGAPORE - Researchers from the National Neuroscience Institute (NNI) are embarking on a ground-breaking project to transplant stem cells into the brains of those with early Parkinson's disease, in a bid to stop the disease in its tracks.
Planning for the first-of-its-kind trial in Singapore is still under way, pending regulatory and ethical approvals.
Researchers are hopeful that the phase one trial for the novel approach can begin in late 2026, with five to eight patients who are younger and facing complications with their current treatments.
The project is being funded under a $25 million research grant awarded on May 28 to the institute by the National Medical Research Council for five years to study Parkinson's disease. The programme is called Singapore Parkinson's Disease Programme, or Sparkle.
An estimated 8,000 people in Singapore live with Parkinson's disease, which happens when dopamine-producing cells in the brain progressively die. As dopamine levels fall, patients present symptoms such as tremors and stiffness, and slowed movement appears. There is no known cure for the neurodegenerative disease, which leads to difficulty with walking, balance, coordination and even speech.
The idea of replacing brain cells killed off by Parkinson's with stem cells has been around for about four decades. The hope is that the transplanted cells, which have the ability to evolve into different types of specialised cells, can then start producing dopamine, reversing the condition.
But progress was held back by ethical considerations and technical hurdles.
Professor Tan Eng King, principal investigator for Sparkle and NNI's deputy chief executive officer for academic affairs, said that in the past, stem cells from embryos and foetuses were used, raising ethical concerns . There were also mixed results, as some transplanted cells did not end up producing dopamine, and led to adverse side effects like involuntary limb movements.
With advancements in cell therapies in recent years, scientists are now able to convert a patient's own normal body cells, such as skin or blood cells, into stem cells.
Using a patient's own cells is a better approach as it reduces the risk of the body's immune system rejecting the transplanted cells.
Prof Tan said NNI has collaborated with Duke-NUS Medical School, Lee Kong Chian School of Medicine and A*Star to develop a proprietary method of converting a person's normal cells into stem cells. The therapy is currently undergoing final approval by the US Food and Drug Administration before it can be used for the trial.
He added that researchers from other countries are also studying similar stem cell approaches for Parkinson's disease.
The most successful group will be the one 'that is able to create a stem cell source from using a patient's own cells that contains almost 100 per cent dopamine-producing cells and nothing else', said Prof Tan.
'This is a very challenging endeavour and it is not something that anybody can do. We have developed the expertise, and we think that potentially, we can be one of the pioneers,' he added.
After the stem cells are transplanted, patients on the trial will likely be monitored for about two years to evaluate the safety and effectiveness of the approach.
Other than the stem cell trial, another initiative under Sparkle is an early screening programme in the community to identify those at high risk of developing Parkinson's disease.
Prof Tan said he is optimistic that the screening programme can be rolled out by the end of 2025, and reach 10,000 people over the age of 55 in the next three to five years.
Currently, in Singapore, there is no screening available to detect those at risk of developing Parkinson's disease.
But Prof Tan said that based on previous research done by NNI, those who suffer from a loss of sense of smell, have rapid eye movement sleep disorder (where people act out their dreams) and a particular gene variant have a higher chance of developing the disease.
The screening will involve a questionnaire, after which those whose results warrant a closer look will be invited to go for more detailed examinations like brain scans.
Those who are identified as having a high risk of developing the disease will be introduced to interventions, including making lifestyle changes in areas such as exercise and diet.
Prof Tan pointed out that Singapore has one of the highest life expectancies in the world.
'If you can reduce the risk of developing a neurodegenerative condition, then you can increase the amount of years that you can spend in healthier living,' he said.
Join ST's WhatsApp Channel and get the latest news and must-reads.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
13 hours ago
- Straits Times
That cup of coffee may have a long-term perk
A study that followed more than 47,000 women in nursing since the 1970s found coffee to contribute to healthy ageing. PHOTO: AFP Most people who drink coffee appreciate the quick jolt of energy it provides. But in a new study, presented on June 2 at the annual meeting of the American Society for Nutrition, scientists have found that coffee may offer the much longer-term benefit of healthy ageing. The study has not been peer-reviewed or published, but it was rigorous and included a large number of women who were followed for many years. It also adds to a large body of evidence linking coffee to longer lives and various health advantages, including lower risks of certain chronic diseases – though all of these studies had limitations, including that they were observational and could not prove cause and effect. Still, the results linking coffee to healthier ageing were not surprising, said Dr Fang Fang Zhang, a professor of nutritional epidemiology at Tufts University who was not involved with the study. 'The data is quite consistent that coffee consumption is actually beneficial,' she said. What did the new research find? In the study, researchers followed more than 47,000 female nurses for several decades beginning in the 1970s. Every few years, the women answered detailed questions about their diets, including how much coffee, tea and cola (like Coca-Cola or Pepsi) they typically drank. Then the scientists looked at how many of the women were still alive and met their definition of 'healthy ageing' in 2016. Just over 3,700 women met that definition: They were 70 or older; reported good physical and mental health, with no cognitive impairment or memory problems; and were free of 11 chronic diseases such as cancer, Type 2 diabetes, heart disease, kidney failure, Parkinson's disease and multiple sclerosis. The researchers found a correlation between how much caffeine the women typically drank (which was mostly from coffee) when they were between 45 and 60 years old and their likelihood of healthy ageing. After adjusting for other factors that could affect ageing, such as their overall diet, how much they exercised and whether they smoked, those who consumed the most caffeine (equivalent to nearly seven 8-ounce cups of coffee per day) had odds of healthy ageing that were 13 per cent higher than those who consumed the least caffeine (equivalent to less than one cup per day). Drinking tea or decaffeinated coffee was not associated with healthy ageing, the researchers found. That may be because the study participants generally consumed less tea and decaffeinated coffee overall, so perhaps there were fewer chances for the researchers to find benefits linked to them, said Dr Sara Mahdavi, an adjunct professor of nutritional sciences at the University of Toronto who led the study. Tea and decaf coffee also have less caffeine, and tea has different plant compounds from regular coffee, so that may explain the results, too, she added. Drinking cola, another potential source of caffeine, was associated with significantly decreased odds of healthy ageing. Dr Mahdavi cautioned that while drinking up to seven small cups of coffee per day was associated with healthy ageing in her study, that doesn't necessarily mean that drinking that much will benefit everyone, or that it is healthy to do so. Research in other groups of people suggests that the health benefits of coffee may plateau or even dip when they drink more than three to four cups per day. What does other research suggest? Many other studies have linked drinking coffee regularly to a lower risk of early death. In a study of more than 46,000 US adults published in May, Dr Zhang and her colleagues found that those who consumed one to three cups of coffee per day were about 15 per cent less likely to die within the next nine to 11 years than those who didn't drink coffee. That benefit disappeared, though, for people who said they typically added more than about a half-teaspoon of sugar to their coffee and for people who added more than 1 gram of saturated fat (equivalent to about one tablespoon of half-and-half or 3.5 tablespoons of whole milk) per cup of coffee. Research has also suggested that people who drink coffee regularly have lower risks of heart disease, Type 2 diabetes, Parkinson's disease, liver disease, osteoporosis and some types of cancer. These kinds of studies can't prove cause and effect, said Dr Aladdin Shadyab, an associate professor of public health and medicine at the University of California, San Diego. But because the benefits associated with coffee have been so consistent, it's unlikely that they are entirely explained by other aspects of a person's life, Dr Zhang said. If anything, drinking coffee is often associated with unhealthy habits, like smoking and less exercise. The fact that you see benefits after accounting for these differences means that coffee is probably helping, Dr Zhang said. How might coffee protect your health? Researchers aren't entirely sure why coffee may be beneficial. 'It's a bit of a mystery,' said Dr Marilyn Cornelis, an associate professor of preventive medicine at Northwestern Feinberg School of Medicine. Studies of mice have found that caffeine may improve memory and protect brain cells from damage. And human studies have found links between regular (not decaffeinated) coffee and a reduced risk of Parkinson's disease. Both regular and decaf coffee contain hundreds of chemical compounds, including many that may lower inflammation and prevent cell damage, Dr Mahdavi said. While the new study didn't find a benefit associated with decaf coffee, other research has linked it, along with regular coffee, to lower rates of Type 2 diabetes and other conditions, Dr Cornelis said. Tea also contains many beneficial compounds, and drinking it has been associated with better heart health and a longer life. What's the takeaway? If you drink coffee regularly, consider the new findings and others like it as good news that it may benefit your health – so long as you don't add too much cream or sugar, Dr Zhang said. But if you don't enjoy coffee, Dr Mahdavi added, there's no need to start drinking it. It can interfere with sleep or make some people feel anxious or jittery. There are plenty of other, more evidence-backed ways to boost your health and longevity, Dr Shadyab added, such as following a balanced diet, exercising regularly, getting enough sleep and having an active social life. NYTIMES Join ST's Telegram channel and get the latest breaking news delivered to you.
Straits Times
a day ago
- Straits Times
Harvard seeks end to US funding cuts, says national security, public health research in peril
FILE PHOTO: Students walk on the campus of Harvard University in Cambridge, Massachusetts, U.S., May 23, 2025. REUTERS/Faith Ninivaggi/File Photo Harvard seeks end to US funding cuts, says national security, public health research in peril WILMINGTON, Delaware - Harvard University asked a federal judge on Monday to issue a summary judgment ruling to unfreeze $2.5 billion in funding blocked by President Donald Trump's administration, which Harvard said was illegal. Harvard's filing in the U.S. District Court in Boston said that it had received 957 orders since April 14 to freeze funding for research pertaining to national security threats, cancer and infectious diseases and more since the country's oldest and wealthiest school rejected a White House list of demands. Trump has said he is trying to force change at Harvard - and other top-level universities across the U.S. - because in his view they have been captured by leftist "woke" thought and become bastions of antisemitism. The Trump administration did not immediately respond to a request for comment. U.S. District Judge Allison Burroughs has set arguments for July 21 on Harvard's motion for summary judgment, which is a request for a judge to decide a dispute without a trial to determine material facts. Harvard sued the Trump administration in April, alleging the funding freeze violated the school's right to free speech and was arbitrary and capricious. In Monday's court filing, Harvard detailed the terminated grants, including $88 million for research into pediatric HIV, $12 million for increasing Defense Department awareness of emerging biological threats and $8 million to better understand dark energy. The school said ending the funding would destroy ongoing research into cancer treatments, infectious disease and Parkinson's. The Trump administration has opened numerous investigations into Harvard. Some are looking at threats against Jewish students and faculty after pro-Palestinian protests broke out following the Oct. 7, 2023 Hamas attack on Israel and subsequent Israeli military actions in Gaza. Other investigations are probing whether Harvard discriminates based on sex and gender, along with the school's ties to foreign governments and international students. The Trump administration revoked Harvard's ability to enroll international students last month, which a judge temporarily blocked after Harvard sued in a separate case. Harvard and other universities say Trump's attacks are threats to freedom of speech and freedom of academics, as well as threats to the schools' very existence. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.
Straits Times
2 days ago
- Straits Times
S'pore researchers to study stem cell transplants in brain for Parkinson's disease in novel trial
Researchers involved in the project include (from left) Professor Lim Kah Leong, President's Chair in Translational Neuroscience at the Lee Kong Chian School of Medicine; Associate Professor Prakash Kumar, head and senior consultant at the department of neurology at the National Neuroscience Institute (NNI); Professor Louis Tan, NNI's director of research; and Professor Tan Eng King, NNI's deputy chief executive officer for academic affairs. ST PHOTO: NG SOR LUAN S'pore researchers to study stem cell transplants in brain for Parkinson's disease in novel trial SINGAPORE - Researchers from the National Neuroscience Institute (NNI) are embarking on a ground-breaking project to transplant stem cells into the brains of those with early Parkinson's disease, in a bid to stop the disease in its tracks. Planning for the first-of-its-kind trial in Singapore is still under way, pending regulatory and ethical approvals. Researchers are hopeful that the phase one trial for the novel approach can begin in late 2026, with five to eight patients who are younger and facing complications with their current treatments. The project is being funded under a $25 million research grant awarded on May 28 to the institute by the National Medical Research Council for five years to study Parkinson's disease. The programme is called Singapore Parkinson's Disease Programme, or Sparkle. An estimated 8,000 people in Singapore live with Parkinson's disease, which happens when dopamine-producing cells in the brain progressively die. As dopamine levels fall, patients present symptoms such as tremors and stiffness, and slowed movement appears. There is no known cure for the neurodegenerative disease, which leads to difficulty with walking, balance, coordination and even speech. The idea of replacing brain cells killed off by Parkinson's with stem cells has been around for about four decades. The hope is that the transplanted cells, which have the ability to evolve into different types of specialised cells, can then start producing dopamine, reversing the condition. But progress was held back by ethical considerations and technical hurdles. Professor Tan Eng King, principal investigator for Sparkle and NNI's deputy chief executive officer for academic affairs, said that in the past, stem cells from embryos and foetuses were used, raising ethical concerns . There were also mixed results, as some transplanted cells did not end up producing dopamine, and led to adverse side effects like involuntary limb movements. With advancements in cell therapies in recent years, scientists are now able to convert a patient's own normal body cells, such as skin or blood cells, into stem cells. Using a patient's own cells is a better approach as it reduces the risk of the body's immune system rejecting the transplanted cells. Prof Tan said NNI has collaborated with Duke-NUS Medical School, Lee Kong Chian School of Medicine and A*Star to develop a proprietary method of converting a person's normal cells into stem cells. The therapy is currently undergoing final approval by the US Food and Drug Administration before it can be used for the trial. He added that researchers from other countries are also studying similar stem cell approaches for Parkinson's disease. The most successful group will be the one 'that is able to create a stem cell source from using a patient's own cells that contains almost 100 per cent dopamine-producing cells and nothing else', said Prof Tan. 'This is a very challenging endeavour and it is not something that anybody can do. We have developed the expertise, and we think that potentially, we can be one of the pioneers,' he added. After the stem cells are transplanted, patients on the trial will likely be monitored for about two years to evaluate the safety and effectiveness of the approach. Other than the stem cell trial, another initiative under Sparkle is an early screening programme in the community to identify those at high risk of developing Parkinson's disease. Prof Tan said he is optimistic that the screening programme can be rolled out by the end of 2025, and reach 10,000 people over the age of 55 in the next three to five years. Currently, in Singapore, there is no screening available to detect those at risk of developing Parkinson's disease. But Prof Tan said that based on previous research done by NNI, those who suffer from a loss of sense of smell, have rapid eye movement sleep disorder (where people act out their dreams) and a particular gene variant have a higher chance of developing the disease. The screening will involve a questionnaire, after which those whose results warrant a closer look will be invited to go for more detailed examinations like brain scans. Those who are identified as having a high risk of developing the disease will be introduced to interventions, including making lifestyle changes in areas such as exercise and diet. Prof Tan pointed out that Singapore has one of the highest life expectancies in the world. 'If you can reduce the risk of developing a neurodegenerative condition, then you can increase the amount of years that you can spend in healthier living,' he said. Join ST's WhatsApp Channel and get the latest news and must-reads.
